Ceva

Libourne, France Founded: 1999 • Age: 27 yrs Acquired By Natixis
Animal health therapeutics are developed and supplied globally by Ceva.

About Ceva

Ceva is a Healthcare company based in Libourne (France) founded in 1999, and was acquired by Natixis in April 2007. Animal health therapeutics are developed and supplied globally by Ceva. It operates in the Healthcare and Agriculture sectors. Ceva has raised $214.35 million across 11 funding rounds from investors including Mitsui & Co, Natixis and Tikehau Capital. Ceva has completed 10 acquisitions, including Aquilón Cyl, Artemis Wildlife Baits and Biotecnofe. Its chief executive, as recorded, is Marc Prikazsky. Its website ceva.com draws about 67 thousand monthly visits. Its Indian entity Ceva Polchem Private Limited reported revenue of ₹145 Cr. Its focus areas include Food and Agriculture Tech, Livestock Tech, Health Management and Pharmaceuticals.

Company details

Ceva was founded in 1999 in Libourne, France, and operates in the animal health sector. Solutions for livestock such as cattle, poultry, sheep, and swine, as well as companion animals, are provided through pharmaceuticals and vaccines. The portfolio encompasses anti-infectives, anti-inflammatories, inactivated vaccines, intravaginal devices, and melatonin. Therapeutic options for conditions like behavioral disorders and renal failures in companion animals are also offered. Domestic and international markets are served.

  • Headquarters Libourne, France
  • Stage Acquired
  • Sectors
    Healthcare
    Agriculture
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website ceva.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Acquired by Natixis (Apr 2007)
  • Legal Name Ceva Polchem Private Limited
  • Date of Incorporation 20 Mar, 2002
Key Metrics
  • Indian entity revenue
    ₹145 Cr

    FY 2025 · +14% YoY

  • Indian entity net profit
    ₹7.98 Cr

    FY 2025 · 6% margin

  • Indian entity EBITDA
    ₹13.43 Cr

    FY 2025 · 9% margin

  • Total Equity Funding
    $214.35M (USD)

    in 11 rounds

  • Latest Funding Round
    $157.69K (USD), Grant

    Jun 2022

  • Investors
  • Investments & Acquisitions
  • Acquired by
    Natixis

    (Apr 2007)

Apps and channels of Ceva

its YouTube channel Ceva TV - Ceva Santé Animale Channel has 617 subscribers and 30 videos.

Ceva TV - Ceva Santé Animale Channel
YouTube 617 subscribers 30 videos Science & Technology
Open channel

Videos from Ceva

The most watched videos on Ceva's YouTube channel, Ceva TV - Ceva Santé Animale Channel (617 subscribers). Click a video to play it here.

2ème Prix de l'agrobiodiversité animale : Le lapin Chèvre
9.7K views
1er Prix de l'agrobiodiversité animale : La vache Ferrandaise
4K views
1er Prix - Le Canard Kriaxera
2.3K views
Ceva Phylaxia 2024
2K views

More on Ceva TV - Ceva Santé Animale Channel.

Funding Insights of Ceva

Ceva has successfully raised a total of $214.35M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $157.69 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $214.35M
  • Total Rounds 11
  • Last Round Grant — $157,688
  • First Round $214.35M

    (Jul 2010)

  • Investors Count 17

Latest 10 of 11 funding rounds of Ceva with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2022$157,688Grant––
Aug 2021$353,889Grant––
Feb 2020Private Equity Round–Temasek
Jun 2017$168,905Grant––
Jan 2017$158,620Grant––
Dec 2016Private Equity Round––
Jul 2014Private Equity Round–Merieux Equity Partners
–
Jun 2014$345.23MDebt – Conventional––
Jun 2014Private Equity Round–Temasek, CDH
Oct 2012Debt – Conventional––
Valuation history

18 investors in total: 18 institutional.

Investors in Ceva

Ceva has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Mitsui & Co, Natixis and Tikehau Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
An investment platform is provided for diverse sectors and geographies.
1974temasek.com.sgSingapore, Singapore
Private equity firm focused on energy, financial services, agriculture, and hospitality services
tethysinvestments.com
Pivate equity firm that focuses on investing in healthcare and nutrition companies
merieux-partners.comLyon, France
Private equity investments are directed across multiple sectors.
2002sagard.comParis, France
VC and PE investments are directed toward multiple sectors.
Beijing, China
Debt and equity investments are managed by the private fund.
2013tikehaucapital.comLondon, United Kingdom
Private investment firm specializing in markets and partnerships.
ardian.com
Private equity investments in France are managed by EMZ Partners.
emzpartners.comParis, France
Private equity and private debt firm focused on multiple sectors
cdhfund.comKowloon, China
economie.gouv.fr
Premium access

Investor details for Ceva

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Ceva Polchem Private Limited (Ceva)

Ceva Polchem Private Limited is the primary company behind Ceva. The board of Ceva Polchem Private Limited currently have 3 directors; the longest-serving is Milind Nagnath Limaye, appointed in 2002. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Milind Nagnath Limaye
DIN 00334854
Whole-time director20 Mar 200224 yrs 7 moCeva Polchem Private Limited
Valerie Claire Aline Mazeaud
DIN 08764433
Director24 Jun 20206 yrs 4 moCeva Polchem Private Limited
Anant Govind Wadkar
DIN 08891471
Director28 Dec 20205 yrs 10 moCeva Polchem Private Limited

People of Ceva

455 people are tracked at Ceva (113 in leadership, 342 in team).

NameRoleGroup
Tothova Tatiana
Managing DirectorLeadership
Marc Prikazsky
CEOLeadership
Theo Kanellos
Group Innovation And Corporate Alliances DirectorLeadership
Ferhat Zatsan
Senior Vice President OperationsLeadership
Valérie Mazeaud
Global Legal DirectorLeadership
Jérôme-André Gauthier
Strategy and Business Development DirectorLeadership
Philip Hall
Head Of OperationsLeadership
Holly Sellers
Director, Scientific Support And Investigation UnitLeadership
Facundo Ocampo
Territory Manager CMO ArgLeadership
Hallie King
Director Of Regulatory AffairsLeadership
Vincent Tabanou
Head Of Global Commercial Operations And Supply Chain QualityLeadership
Marc Colson
Vice President, Global Industrial Development - Pharma & BiologicsLeadership
Elias Assaf
Operational Director - Near East And GulfLeadership
Pascal Anjot
Global Portfolio Innovation and Development DirectorLeadership
Fricefel Ureta
CFOLeadership
Jana Vesela
Country CFO & Admin. Manager Ceva Czech Republic & SlovakiaLeadership
Leanne Grechulk
Marketing DirectorLeadership
Gordon Gow
Head Of Key AccountsLeadership
Akay Ozturk
Poultry & Companion Animals Business Unit DirectorLeadership
Edouard Timsit
Director Of Global Innovation Livestock Health And SustainabilityLeadership

435 more people are available in the full profile.

Premium access

Complete people profiles for Ceva

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Ceva

Figures of Ceva Polchem Private Limited, the primary company behind Ceva, for FY 2025. Revenue was ₹145 Cr (+14% year on year). Net profit was ₹7.98 Cr (6% margin). EBITDA was ₹13.43 Cr (9% margin). Revenue has grown at a compounded annual rate of +16% over three years and +10% over five years.

  • ₹145 CrRevenue · FY 2025 · +14% YoY
  • ₹7.98 CrNet profit · 6% margin
  • ₹13.43 CrEBITDA · 9% margin
  • ₹1.75 CrPaid-up capital
  • 163Employees (provident fund records)
  • +16%Revenue CAGR, 3 years
  • +10%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ceva Polchem Private Limited are on its company page.

Premium access

Detailed financial statements for Ceva

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ceva

Ceva has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Aquilón Cyl, Artemis Wildlife Baits and Biotecnofe.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Products enhancing animal productivity are developed and marketed.
aquiloncyl.comLeon, Spain2012Jun 2026••••
Manufacturer of protein therapeutics for animal health
scoutbio.coPhiladelphia, United States2017Jan 2024••••
Veterinary biotherapeutics research and development services are offered.
biotecnofe.com.arSanta Fe, Argentina2018Dec 2022••••
Provider of veterinary health products
zoovet.com.arSanta Fe, Argentina1998Dec 2022••••
Rabies vaccine for animals is developed in coated capsules.
artemiswildlifebaits.comGuelph, Canada1997May 2022••••
Center pivot irrigation components and controls are distributed worldwide.
thunderworks.comDurham, United States2009Jul 2019••••
Veterinary nutritional supplements, intravaginal devices, and drugs are manufactured.
inovabiotecnologia.com.brBelo Horizonte, Brazil2006Nov 2016••••
Medical research laboratory services for animal health are provided.
hertape.com.brBelo Horizonte, Brazil1943Nov 2016••••
Development services for veterinary vaccines and pharmaceutical products are provided.
sogeval.frFrance1997Dec 2013••••
Veterinary health products are supplied for animal care needs.
centaurva.comGuelph, Canada2017Oct 2011••••
Premium access

Complete acquisition details for Ceva

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Ceva

14 dated milestones of Ceva across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ceva is founded.
  2. Exit Acquired by Natixis.
  3. Funding First funding round of $214.4M.
  4. Acquisition Acquires Centaur VA Animal Health.
  5. Acquisition Acquires Sogeval.fr.
  6. Acquisition Acquires Inova Biotecnologia Saude Animal.
  7. Acquisition Acquires HERTAPE SAUDE ANIMAL.
  8. Acquisition Acquires Thunderworks.
  9. Acquisition Acquires Artemis Wildlife Baits.
  10. Funding Latest funding round, Grant, of $158K.
  11. Acquisition Acquires Zoovet Productos Veterinarios.
  12. Acquisition Acquires Biotecnofe.
  13. Acquisition Acquires Scout Bio.
  14. Acquisition Acquires Aquilón Cyl.

Web traffic of Ceva

The website of Ceva (ceva.com) receives about 66.9K visits a month and ranks #450,724 among all websites worldwide, #420 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    66.9K

    ▼ 13% vs previous month

  • Unique visitors
    31.5K

    per month

  • Global rank
    #450,724

    among all websites

  • Category rank
    #420

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Ceva. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
chene-vert.com
chene-vert.com
100%
–
intervet.fr
intervet.fr
100%
–
proclinical.com
94%
63.8K#560,331View details
ceva-santeanimale.fr
ceva-santeanimale.fr
69%
#4,696,271–
picuida.es
69%
#1,134,203View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 13 similar websites and full traffic analytics for Ceva

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ceva

Premium access

Complete news archive for Ceva

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ceva

Ceva was founded in 1999 and raised its 1st funding round 11 years after it was founded.

Ceva is headquartered in Libourne, France. It is registered at Libourne, Nouvelle-aquitaine, France.

Marc Prikazsky is the CEO of Ceva, as recorded in our data.

Ceva is a funded company, having raised a total of $214.35M across 11 funding rounds to date.

The primary company behind Ceva, Ceva Polchem Private Limited, reported revenue of ₹145 Cr for FY 2025, up 14% year on year.

Ceva was founded in 1999 in Libourne, France, and operates in the animal health sector. Solutions for livestock such as cattle, poultry, sheep, and swine, as well as companion animals, are provided through pharmaceuticals and vaccines. The portfolio encompasses anti-infectives, anti-inflammatories, inactivated vaccines, intravaginal devices, and melatonin. Therapeutic options for conditions like behavioral disorders and renal failures in companion animals are also offered. Domestic and international markets are served.

Ceva has made 10 acquisitions, including Aquilón Cyl, Artemis Wildlife Baits, and Biotecnofe.

Ceva has 18 investors. Key investors include Mitsui & Co, Natixis, Tikehau Capital, Temasek, and Sagard.

Ceva operates through Ceva Polchem Private Limited.

Yes. Ceva was acquired by Natixis in April 2007.

The legal entities of Ceva currently have 3 directors, including Valerie Claire Aline Mazeaud, Anant Govind Wadkar, Milind Nagnath Limaye.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available